Omeprazole, a proton pump inhibitor (PPI), is widely used for the treatment of dyspepsia, peptic ulcer, gastroesophageal reflux disease, and functional dyspepsia. Polypharmacy is common in patients receiving omeprazole. Drug toxicity and treatment failure
Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause. The Functional (Non Ulcer) Dyspepsia Drugs market report provides an overview of the Functional (Non Ulcer) Dyspepsia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Functional (Non Ulcer) Dyspepsia, complete with analysis by
medication. Acotiamide, Acotiamide has been used in trials studying the treatment of Dyspepsia and Functional Dyspepsia. Drugs Drug Targets. Drug, Target
They were diarrhea, dyspepsia and abdominal pain. Discontinuation of therapy due to these adverse events was 1.3% (diarrhea), 0.8% (dyspepsia)
Dyspepsia: Dyspepsia is a frequent reaction characterized by indigestion, heartburn, and abdominal discomfort. Tadalafil's relaxation effect on gastrointestinal smooth
Drug treatment. Drugs that may cause dyspepsia, such as alpha-blockers In patients with uninvestigated dyspepsia taking an NSAID and unable to stop the drug
Peptic ulcer disease (gastric or duodenal ulcers). Functional dyspepsia (non-ulcer dyspepsia). Dyspepsia symptoms are estimated to occur in about 40% of the
Drugs-for-dyspepsia Alimentary Pharmacology Therapeutics: Functional dyspepsia is characterised by troublesome early satiety, fullness, or epigastric pain
Gabapentin as an adjunctive drug could be more effective in reducing the severity of GI symptoms in patients with dyspepsia, especially neurological symptoms (such as pain, reflux, and indigestion). Keywords: Functional dyspepsia, gabapentin, gastrointestinal disorders. Go to: Introduction.
Comments